With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
Related Posts
Dimon Warns That Private Credit May Be at Its Peak
The JPMorgan Chase chief has long been skeptical of the nontraditional, and less regulated, lending business. Now he thinks its best days may be over.
‘No Smoking’ Sign on Planes Won’t Need Off Switch After FAA Rule Change
The Federal Aviation Administration did away with a rule that had required an off switch for the sign even though smoking on U.S. flights ended […]
Evan Gershkovich, U.S. Journalist Imprisoned in Russia, Will Publish a Memoir
The memoir, which will cover his time in prison and Russia’s move toward autocracy, will be published by Crown, an imprint of Penguin Random House.